Phase II study of S-1 in patients with advanced biliary tract cancer.
about
Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesFeasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer.Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective studyA phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma.Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer.A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer.A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer.A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.Rational therapeutic strategy for T2 gallbladder carcinoma based on tumor spread.Successful curative resection of gallbladder cancer following S-1 chemotherapy: A case report and review of the literature.Guidelines for chemotherapy of biliary tract and ampullary carcinomasRecent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer.Surgical procedure and long-term survival of hilar cholangiocarcinoma.Cholangiocarcinoma: prognostic factors after surgical resection in China.Improvement of prognosis for unresectable biliary tract cancer.Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer.A Case of Common Bile Duct Cancer That Completely Responded to Combination Chemotherapy of Gemcitabine and TS-1.Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Emerging drugs for biliary cancer.Current status of chemotherapy for the treatment of advanced biliary tract cancer.The role of chemotherapy in biliary tract carcinoma.Multidisciplinary collaboration in gallbladder carcinoma treatment: A case report and literature reviewCombined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial.A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy.Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis.Chemotherapy for the biliary tract cancers: moving toward improved survival time.Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy.Long-term survival of a recurrent gallbladder carcinoma patient with lymph node and peritoneal metastases after multidisciplinary treatments: a case report.Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition.Signaling pathways as therapeutic targets in biliary tract cancer.
P2860
Q30234532-4FDA65D7-4E1F-426C-A569-422CCC8FDE88Q30300756-8AC81FEB-03FE-417A-883E-E4584E74066AQ33390549-F5005038-A4DE-41DA-8C7A-7738740D63A9Q33391003-DA14230F-231B-4725-B82F-C702DB77C3F6Q33391729-94FF4A1E-35BC-406C-80AB-224299CEFD06Q33394065-57F68F1F-C2A9-461B-B88D-5940B1700D0CQ33398969-70E6EE6F-E2E8-4194-A734-B2FF5FE1DDFFQ33401071-3E9B6587-0D7C-4A3C-A574-5DA042BE944EQ33402129-F9506EC0-2ACC-48EA-B67D-E4A4786E2200Q33417107-0727293F-3C0E-4936-9B2B-C527D61C0197Q33419175-B0D5761E-B3CF-4E16-8A01-84D920E03233Q33420043-EFFF1E63-2266-4302-B3F7-611D0091FED5Q33423185-B76DF554-9341-42B2-A11E-76B666E1F878Q33430668-22809484-B465-402C-81FD-D20CC5FB4D6DQ33506777-0F373299-5B37-4BF6-AC5F-67D5012143F2Q34018271-BE3B0C9A-EF90-4048-9E1A-9F613D1B7856Q34427188-5941F04E-8194-4DEB-8A72-2FE445EC5DF5Q34588361-5F300D02-81D2-4A23-8B1F-6CEDAEAF5024Q35000796-8784868A-8BF3-485C-AFD1-37D54CB513FCQ35004744-F8A8F211-4E16-493D-B917-293286458270Q35173757-3A336A38-9599-4DE7-BE31-53D95FE8503BQ35791442-3AE4B7DA-BABD-4420-8AEE-A3778A8FA82EQ36525533-46E23886-637F-42AF-AA18-B439ABC00640Q36615451-C5821B9E-398F-448C-8324-E70783CAC81BQ36795363-20060A88-93CF-40AD-B5C4-2C470AAE9B58Q36868758-98E5AF90-3294-42E3-9D91-E4F163DBC19FQ36962011-5657668C-8A16-4285-AC18-C935AC6F62F6Q36989921-4C34B385-B0AA-47F1-8BFF-7A0D6E102A03Q37138732-2275C45A-6B78-451F-81E6-99C4155B4C61Q37261360-327F8AFB-4811-4554-8CCD-DE4204AB1101Q37288576-28E4348F-CFAB-4BEA-A94C-E30DFAA5E597Q37295836-D6C433A3-5F19-46CA-907E-EB7E7B8E1C31Q37413339-3F856FDC-D119-4BF2-8E41-3D99C77EB9CFQ37784142-C1BDAE7D-D6DD-4C53-BE6E-4AACD3C85BB1Q37983498-C909D5F9-7491-4AD7-8499-37F41AE7F955Q38030862-29866B0D-A19D-45FC-9686-FFAC595BF312Q38183813-3B33A66E-8C8A-4F8C-B62A-6F7B03BBB56BQ38372400-E6603BB8-125C-48A4-8043-46CE2DE7A122Q38383198-D6476862-9797-4800-AEEB-3904A5799003Q38747573-CB8EE9E5-7B86-4693-8F4B-AF603A985023
P2860
Phase II study of S-1 in patients with advanced biliary tract cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Phase II study of S-1 in patients with advanced biliary tract cancer.
@ast
Phase II study of S-1 in patients with advanced biliary tract cancer.
@en
type
label
Phase II study of S-1 in patients with advanced biliary tract cancer.
@ast
Phase II study of S-1 in patients with advanced biliary tract cancer.
@en
prefLabel
Phase II study of S-1 in patients with advanced biliary tract cancer.
@ast
Phase II study of S-1 in patients with advanced biliary tract cancer.
@en
P2093
P2860
P356
P1476
Phase II study of S-1 in patients with advanced biliary tract cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602208
P407
P577
2004-11-01T00:00:00Z